Stockreport

Eli Lilly Falls 5% — FDA Oral Obesity Pill Decision and Novo Nordisk Rivalry Weigh on Shares [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Moreover, shares of Eli Lilly rival Novo Nordisk (NVO) are down 25% year to date as competition in the oral GLP-1 space intensifies. The LLY stock selloff reflects co [Read more]